| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 口服制剂(元) | 33,576,843.78 | 60,866,846.83 | 58,298,705.47 |
| 原料药(元) | 5,577,599.77 | 11,542,395.14 | 3,209,447.29 |
| 注射剂(元) | 68,730,734.04 | 192,832,691.84 | 337,000,793.80 |
| 营业成本(元) | |||
| 口服制剂(元) | 7,913,762.33 | 12,828,187.11 | 13,689,080.80 |
| 原料药(元) | 2,364,473.01 | 8,682,310.55 | 4,094,778.75 |
| 注射剂(元) | 25,122,552.70 | 56,115,219.74 | 60,515,069.48 |
| 毛利(元) | |||
| 口服制剂(元) | 25,663,081.45 | 48,038,659.72 | 44,609,624.67 |
| 原料药(元) | 3,213,126.76 | 2,860,084.59 | -885,331.46 |
| 注射剂(元) | 43,608,181.34 | 136,717,472.10 | 276,485,724.32 |
| 毛利率(%) | |||
| 口服制剂(%) | 76.43 | 78.92 | 76.52 |
| 原料药(%) | 57.61 | 24.78 | -27.59 |
| 注射剂(%) | 63.45 | 70.90 | 82.04 |
| 收入构成(%) | |||
| 口服制剂(%) | 31.12 | 22.95 | 14.63 |
| 原料药(%) | 5.17 | 4.35 | 0.81 |
| 注射剂(%) | 63.71 | 72.70 | 84.57 |
| 毛利构成(%) | |||
| 口服制剂(%) | 35.40 | 25.60 | 13.93 |
| 原料药(%) | 4.43 | 1.52 | -0.28 |
| 注射剂(%) | 60.16 | 72.87 | 86.35 |